Variant report
Variant | nsv571479 |
---|---|
Chromosome Location | chr16:12719799-12733267 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11075132 | chr16:12719799-12719800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534502027 | chr16:12719807-12719808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11643640 | chr16:12719816-12719817 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs540560623 | chr16:12719823-12719824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147890105 | chr16:12719832-12719833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539901652 | chr16:12719847-12719848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs556711823 | chr16:12719857-12719858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183102386 | chr16:12719879-12719880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545955528 | chr16:12719901-12719902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576478169 | chr16:12719905-12719906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550337524 | chr16:12719910-12719911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs116246077 | chr16:12719922-12719923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547967060 | chr16:12719930-12719931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs370908556 | chr16:12719932-12719933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568080151 | chr16:12719942-12719943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs527268662 | chr16:12719951-12719952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs547733614 | chr16:12719954-12719955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375458090 | chr16:12719955-12719956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368795336 | chr16:12719956-12719957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs76542720 | chr16:12719968-12719969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187398932 | chr16:12719972-12719973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76774234 | chr16:12719976-12719977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191882337 | chr16:12719989-12719990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569745735 | chr16:12719993-12719994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538378690 | chr16:12719995-12719996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145448365 | chr16:12719998-12719999 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542274464 | chr16:12720002-12720003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs562230981 | chr16:12720008-12720009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs554063256 | chr16:12720009-12720010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs577084956 | chr16:12720010-12720011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112234937 | chr16:12720015-12720016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545992340 | chr16:12720021-12720022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185165178 | chr16:12720029-12720030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531795439 | chr16:12720048-12720049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs59912173 | chr16:12720049-12720050 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs117328944 | chr16:12720055-12720056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs530943390 | chr16:12720056-12720057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564653403 | chr16:12720059-12720060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs547376458 | chr16:12720061-12720062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs570761560 | chr16:12720068-12720069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs57435935 | chr16:12720071-12720072 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs550089690 | chr16:12720073-12720074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569867815 | chr16:12720074-12720075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188437333 | chr16:12720077-12720078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs144985080 | chr16:12720079-12720080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs568428510 | chr16:12720083-12720084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533943987 | chr16:12720084-12720085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs56058304 | chr16:12720093-12720094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs386789185 | chr16:12720100-12720101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12448911 | chr16:12720102-12720103 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 17603634 | CNVD |
Hodgkin''s lymphoma | 20651079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 16608533 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 22566537 | CNVD |
Intellectual disability | 22566537 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Lung cancer | 18438408 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22102821 | CNVD |
Autism | 22495311 | CNVD |
idiopathic generalized epilepsy | 19843651 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Intellectual disability | 22102821 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Prostate cancer | 18632612 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 19786961 | CNVD |
Mental retardation | 19786961 | CNVD |
Schizophrenia | 19786961 | CNVD |
Mental retardation | 19951919 | CNVD |
Autism | 18791038 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Autism | 17480035 | CNVD |
Schizophrenia | 19955444 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 17847001 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:12708600-12719800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr16:12719800-12720000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr16:12720000-12720200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr16:12720200-12720600 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr16:12720600-12721000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr16:12721200-12723600 | Enhancers | A549 | lung |
7 | chr16:12721800-12723200 | Enhancers | HUVEC | blood vessel |
8 | chr16:12722200-12723000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr16:12723600-12724400 | Enhancers | HepG2 | liver |
10 | chr16:12724400-12734800 | Weak transcription | HepG2 | liver |
11 | chr16:12724800-12725000 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
12 | chr16:12730800-12731200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr16:12730800-12731200 | Enhancers | H1 Cell Line | embryonic stem cell |
14 | chr16:12730800-12731400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
15 | chr16:12730800-12731400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
16 | chr16:12731000-12731200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr16:12731000-12733400 | Enhancers | Placenta | Placenta |
18 | chr16:12732600-12733400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
19 | chr16:12732800-12733000 | Enhancers | Muscle Satellite Cultured Cells | -- |
20 | chr16:12732800-12733400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
21 | chr16:12733200-12733400 | Enhancers | Osteobl | bone |